William Blair Initiates Coverage On Solid Biosciences with Outperform Rating, Announces Price Target of $40

Solid Biosciences -8.97% Post

Solid Biosciences

SLDB

6.80

6.80

-8.97%

0.00% Post

William Blair analyst Tim Lugo initiates coverage on Solid Biosciences (NASDAQ: SLDB) with a Outperform rating and announces Price Target of $40.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via